Chile salmon industry frantically seeks silver bullet for deadly disease

With $700 million in annual losses, the SRS bacteria "has gone way beyond any limit without anything on the horizon that could really solve things," one expert says.

Has vaccine company Vaxxinova found a potential solution?
Has vaccine company Vaxxinova found a potential solution?Photo: Nofima
Published 20 September 2022, 06:00Updated 20 September 2022, 12:55